Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs J.B.CHEMICALS - Comparison Results

DISHMAN PHARMA     Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA J.B.CHEMICALS DISHMAN PHARMA/
J.B.CHEMICALS
 
P/E (TTM) x 25.1 32.9 76.1% View Chart
P/BV x 3.3 6.1 54.6% View Chart
Dividend Yield % 0.7 0.2 346.1%  

Financials

 DISHMAN PHARMA   J.B.CHEMICALS
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
J.B.CHEMICALS
Mar-18
DISHMAN PHARMA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs374363 103.1%   
Low Rs129255 50.5%   
Sales per share (Unadj.) Rs197.8169.1 116.9%  
Earnings per share (Unadj.) Rs21.216.6 127.8%  
Cash flow per share (Unadj.) Rs34.723.4 148.3%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Dividend yield (eoy) %0.80.6 122.8%  
Book value per share (Unadj.) Rs179.9172.5 104.3%  
Shares outstanding (eoy) m80.6983.57 96.6%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x1.31.8 69.6%   
Avg P/E ratio x11.918.6 63.7%  
P/CF ratio (eoy) x7.213.2 54.9%  
Price / Book Value ratio x1.41.8 78.1%  
Dividend payout %9.412.0 78.3%   
Avg Mkt Cap Rs m20,30625,827 78.6%   
No. of employees `0000.83.8 22.0%   
Total wages/salary Rs m5,3552,511 213.3%   
Avg. sales/employee Rs Th19,252.73,747.4 513.8%   
Avg. wages/employee Rs Th6,459.5665.7 970.3%   
Avg. net profit/employee Rs Th2,064.1367.8 561.2%   
INCOME DATA
Net Sales Rs m15,96114,135 112.9%  
Other income Rs m265366 72.6%   
Total revenues Rs m16,22614,501 111.9%   
Gross profit Rs m4,1032,178 188.4%  
Depreciation Rs m1,091570 191.4%   
Interest Rs m94435 2,706.0%   
Profit before tax Rs m2,3341,940 120.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624552 112.9%   
Profit after tax Rs m1,7111,387 123.3%  
Gross profit margin %25.715.4 166.8%  
Effective tax rate %26.728.5 93.8%   
Net profit margin %10.79.8 109.2%  
BALANCE SHEET DATA
Current assets Rs m11,01810,470 105.2%   
Current liabilities Rs m9,5172,749 346.2%   
Net working cap to sales %9.454.6 17.2%  
Current ratio x1.23.8 30.4%  
Inventory Days Days11055 200.2%  
Debtors Days Days3578 44.9%  
Net fixed assets Rs m16,3045,811 280.6%   
Share capital Rs m161167 96.6%   
"Free" reserves Rs m12,90714,248 90.6%   
Net worth Rs m14,51614,416 100.7%   
Long term debt Rs m4,1890-   
Total assets Rs m29,80517,649 168.9%  
Interest coverage x3.556.6 6.1%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.50.8 66.9%   
Return on assets %8.98.1 110.6%  
Return on equity %11.89.6 122.5%  
Return on capital %17.513.7 128.0%  
Exports to sales %24.80-   
Imports to sales %3.70-   
Exports (fob) Rs m3,956NA-   
Imports (cif) Rs m596NA-   
Fx inflow Rs m4,9526,164 80.3%   
Fx outflow Rs m6971,334 52.2%   
Net fx Rs m4,2554,829 88.1%   
CASH FLOW
From Operations Rs m2,7861,231 226.4%  
From Investments Rs m-1,529-208 734.7%  
From Financial Activity Rs m-941-595 158.1%  
Net Cashflow Rs m316427 74.1%  

Share Holding

Indian Promoters % 61.4 55.4 110.8%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 3.7 3.4 109.1%  
FIIs % 12.7 3.9 325.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 22.1 37.0 59.7%  
Shareholders   46,261 30,437 152.0%  
Pledged promoter(s) holding % 35.8 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   GSK PHARMA  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare DISHMAN PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Momentum Moves: The Week Gone By(Momentum Moves)

Nifty and Sensex ended the week gaining 0.60% and 0.52% respectively. Bulls started the week roaring but since Wednesday, the momentum seemed to be tiring.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Five Wishes and a Will(The Honest Truth)

Jan 4, 2021

Ajit Dayal on the investing strategy for 2021 and beyond.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DISHMAN PHARMA SHARE PRICE


May 29, 2017 (Close)

TRACK DISHMAN PHARMA

  • Track your investment in DISHMAN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DISHMAN PHARMA

DISHMAN PHARMA 5-YR ANALYSIS

COMPARE DISHMAN PHARMA WITH

MARKET STATS